IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 89 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $333,000 | -74.6% | 20,000 | -70.9% | 0.22% | -72.6% |
| Q4 2021 | $1,313,000 | -80.6% | 68,800 | -75.0% | 0.79% | -78.9% |
| Q3 2021 | $6,776,000 | +87.5% | 274,761 | +97.8% | 3.73% | +65.0% |
| Q2 2021 | $3,614,000 | -9.0% | 138,886 | +15.2% | 2.26% | +19.7% |
| Q3 2020 | $3,970,000 | -32.7% | 120,606 | -43.9% | 1.89% | -25.5% |
| Q2 2020 | $5,902,000 | -64.4% | 215,000 | -61.1% | 2.53% | -67.3% |
| Q1 2020 | $16,557,000 | +53.9% | 553,100 | +42.3% | 7.74% | +63.9% |
| Q4 2019 | $10,756,000 | +70.7% | 388,600 | +12.3% | 4.72% | +35.1% |
| Q3 2019 | $6,300,000 | -35.8% | 346,149 | -13.5% | 3.50% | -29.3% |
| Q2 2019 | $9,808,000 | +12.5% | 400,000 | -56.4% | 4.94% | +29.6% |
| Q1 2019 | $8,721,000 | -7.3% | 917,080 | -13.7% | 3.82% | -21.4% |
| Q4 2018 | $9,403,000 | +16.9% | 1,062,500 | +48.5% | 4.85% | +8.2% |
| Q3 2018 | $8,047,000 | +42.9% | 715,317 | +62.6% | 4.49% | +8.7% |
| Q2 2018 | $5,631,000 | +58.8% | 439,900 | +109.6% | 4.13% | +85.6% |
| Q1 2018 | $3,546,000 | -12.6% | 209,842 | -58.6% | 2.22% | -25.4% |
| Q4 2017 | $4,055,000 | – | 506,852 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |